Hyundai Bioscience

048410.KQ

4.39 USD

0.00

0.00%

Overview

Last close

4.39 usd

Market cap

423.22M usd

52 week high

13.86 usd

52 week low

3.13 usd

Target price

N/A usd

Valuation

P/E

N/A

Forward P/E

N/A

Price/Sales

169.7149

Price/Book Value

5.5489

Enterprise Value

413.48M usd

EV/Revenue

166.6643

EV/EBITDA

-64.6317

Key financials

Revenue TTM

2.48M usd

Gross Profit TTM

-187250.64 usd

EBITDA TTM

-13.35M usd

Earnings per Share

-0.2 usd

Dividend

N/A usd

Total assets

84.85M usd

Net debt

2.74M usd

About

Hyundai Bioscience Co., Ltd. operates as a biotechnology company. The company provides Vitabrid C12, a vitamin C product that delivers active vitamin C into the skin. It develops Polytaxel, a drug for pancreatic cancer and solid tumors; and CP-COV03 drug for Covid 19. The company was founded in 2000 and is based in Seoul, South Korea.